Want to track KURN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kuros Biosciences AG (KURN) Statistics
Valuation metrics
Market Cap 933.14M
Enterprise value 897.75M
Trailing P/E (ttm) 541.31
Forward P/E 38.2
PEG ratio 10.6
Price/Sales (ttm) 7.02
Price/Book (mrq) 13.49
Enterprise Value/Revenue 6.93
Enterprise Value/EBITDA 88.04
Overview
Shares outstanding 39.15M
Float 28.87M
Shares short -
% Held by insiders 0.29%
% Held by institutions 0.21%
Average volume (10 days) 202.18K
Average volume (90 days) 174.24K
Price summary
52-Week low 17.69
52-Week high 34.2
Beta 0.7
50-Day moving average 20.51
200-Day moving average 22.75
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 826:761
Last split Date 8 Oct 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2013
Profitability
Profit margin 0.01%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 114.65M
Revenue per share (ttm) 3.31
Quarterly revenue growth (yoy) 0.67%
Gross profit (ttm) 100.04M
EBITDA 8.75M
Net income to common (ttm) 1.93M
Diluted EPS (ttm) 0.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 15.52M
Total cash per share (mrq) 0.4
Total debt (mrq) 1.09M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 1.96%
Book value per share (mrq) 1.71
Cash Flow
Cash flow statement -357.17K
Levered free cash flow (LFCF) -3.09M
